Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins

Research output: Contribution to journalArticle

Standard

Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins. / Darvall, Katy; Bate, GR; Silverman, Stanley; Adam, Donald; Bradbury, Andrew.

In: British Journal of Surgery, Vol. 96, No. 11, 01.11.2009, p. 1268-1273.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{e9a8fd7dd28147e0b636f729d6727404,
title = "Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins",
abstract = "Background: The results of surgery for small saphenous varicose vein (SSV) varicosities may be suboptimal in terms of recurrence and complications. The role of minimally invasive alternatives remains incompletely defined. The aim was to review the medium-term outcomes of ultrasound-guided foam sclerotherapy (UGFS) for SSV. Methods: Eighty-six patients (92 legs) undergoing UGFS for SSV were assessed before, and 1, 6 and 12 months after treatment. Outcome measures were occlusion of, and abolition of reflux in, the SSV (technical success), absence of visible varicose veins (clinical success) and improvement in disease-sped fie health-related quality of life (HRQL) following treatment (Aberdeen Varicose Vein Symptom Severity Score (AVSS)). Results: The technical and clinical Success rates at 12 months were 91 and 93 per cent respectively; only three patients required a second treatment. After treatment of isolated SSV varicosities there was a significant improvement in AVSS, from a median of 19-0 (interquartile range 13.4-26-9) before treatment to 10.2 (4.0-18.3) and 9.7 (3.5-19.1) at 6 and 12 months respectively. The only complication was a popliteal vein thrombosis that required anti coagulation. Conclusion: UGFS was an effective treatment for SSV, with abolition of reflux and visible varicose veins, and improvement in HRQL for at least 12 months.",
author = "Katy Darvall and GR Bate and Stanley Silverman and Donald Adam and Andrew Bradbury",
year = "2009",
month = nov,
day = "1",
doi = "10.1002/bjs.6755",
language = "English",
volume = "96",
pages = "1268--1273",
journal = "British Journal of Surgery",
issn = "0007-1323",
publisher = "Wiley",
number = "11",

}

RIS

TY - JOUR

T1 - Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins

AU - Darvall, Katy

AU - Bate, GR

AU - Silverman, Stanley

AU - Adam, Donald

AU - Bradbury, Andrew

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Background: The results of surgery for small saphenous varicose vein (SSV) varicosities may be suboptimal in terms of recurrence and complications. The role of minimally invasive alternatives remains incompletely defined. The aim was to review the medium-term outcomes of ultrasound-guided foam sclerotherapy (UGFS) for SSV. Methods: Eighty-six patients (92 legs) undergoing UGFS for SSV were assessed before, and 1, 6 and 12 months after treatment. Outcome measures were occlusion of, and abolition of reflux in, the SSV (technical success), absence of visible varicose veins (clinical success) and improvement in disease-sped fie health-related quality of life (HRQL) following treatment (Aberdeen Varicose Vein Symptom Severity Score (AVSS)). Results: The technical and clinical Success rates at 12 months were 91 and 93 per cent respectively; only three patients required a second treatment. After treatment of isolated SSV varicosities there was a significant improvement in AVSS, from a median of 19-0 (interquartile range 13.4-26-9) before treatment to 10.2 (4.0-18.3) and 9.7 (3.5-19.1) at 6 and 12 months respectively. The only complication was a popliteal vein thrombosis that required anti coagulation. Conclusion: UGFS was an effective treatment for SSV, with abolition of reflux and visible varicose veins, and improvement in HRQL for at least 12 months.

AB - Background: The results of surgery for small saphenous varicose vein (SSV) varicosities may be suboptimal in terms of recurrence and complications. The role of minimally invasive alternatives remains incompletely defined. The aim was to review the medium-term outcomes of ultrasound-guided foam sclerotherapy (UGFS) for SSV. Methods: Eighty-six patients (92 legs) undergoing UGFS for SSV were assessed before, and 1, 6 and 12 months after treatment. Outcome measures were occlusion of, and abolition of reflux in, the SSV (technical success), absence of visible varicose veins (clinical success) and improvement in disease-sped fie health-related quality of life (HRQL) following treatment (Aberdeen Varicose Vein Symptom Severity Score (AVSS)). Results: The technical and clinical Success rates at 12 months were 91 and 93 per cent respectively; only three patients required a second treatment. After treatment of isolated SSV varicosities there was a significant improvement in AVSS, from a median of 19-0 (interquartile range 13.4-26-9) before treatment to 10.2 (4.0-18.3) and 9.7 (3.5-19.1) at 6 and 12 months respectively. The only complication was a popliteal vein thrombosis that required anti coagulation. Conclusion: UGFS was an effective treatment for SSV, with abolition of reflux and visible varicose veins, and improvement in HRQL for at least 12 months.

U2 - 10.1002/bjs.6755

DO - 10.1002/bjs.6755

M3 - Article

C2 - 19847863

VL - 96

SP - 1268

EP - 1273

JO - British Journal of Surgery

JF - British Journal of Surgery

SN - 0007-1323

IS - 11

ER -